ADVERTISEMENT

ICICI Direct: Alembic Pharma Q2 Review - Strong Growth In Rest of World, API; Margins Upbeat

Alembic Pharma’s Q2 revenue was in line with estimates while profitability was better than expected.

An employee collects a handful of tablets as they exit a Fette Compacting 2090i machine (Photographer Krisztian Bocsi/Bloomberg)
An employee collects a handful of tablets as they exit a Fette Compacting 2090i machine (Photographer Krisztian Bocsi/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More